Molecule Details
InChIKeyGYLDXIAOMVERTK-UHFFFAOYSA-N
Compound NameSapanisertib
Canonical SMILESCC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)9
Pfam Stratification Cross-Family
Avg pChEMBL8.23
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11836
Drug NameSapanisertib
CAS Number1224844-38-5
Groups investigational
ATC Codes nan
DescriptionSapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others.

Categories: Heterocyclic Compounds, Fused-Ring Purines
Cross-references: BindingDB: 315477 ChEBI: 91450 CHEMBL3545097 ChemSpider: 28189069 PDB: FE5 PubChem:45375953 PubChem:347828181 RxCUI: 2395271 Wikipedia: Sapanisertib ZINC: ZINC000073069271
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
Q8N122 RPTOR Homo sapiens Human PF02985 PF14538 PF00400 9.0 IC50 ChEMBL
Q9BVC4 MLST8 Homo sapiens Human PF00400 9.0 IC50 ChEMBL;BindingDB
P42345 MTOR Homo sapiens Human PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 8.8 IC50 ChEMBL;BindingDB
P48736 PIK3CG Homo sapiens Human PF00454 PF00792 PF00794 PF00613 PF19710 8.4 Kd ChEMBL;BindingDB
Q6R327 RICTOR Homo sapiens Human PF14663 PF14666 PF14664 PF14665 PF14668 8.3 IC50 ChEMBL
Q9BPZ7 MAPKAP1 Homo sapiens Human PF16978 PF25322 PF05422 PF16979 8.3 IC50 ChEMBL;BindingDB
P42336 PIK3CA Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.5 Ki ChEMBL;BindingDB
O00329 PIK3CD Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.5 Kd ChEMBL;BindingDB
P42338 PIK3CB Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.1 Kd ChEMBL;BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P42345 MTOR Serine/threonine-protein kinase mTOR inhibitor targets